Multimodal therapeutic approach

1. Multimodal therapeutic approach is associated with urine protein-to-creatinine ratio in humans (>16,000 mg/g to ~6,200 mg/g).

   “Over 14 months, her serum creatinine stabilized at 1.45 mg/dL, MPO titers decreased to 28 AI, and proteinuria improved to ~6,200 mg/g.”

   HumansOverlapping ANCA-associated vasculitis, diabetic nephropathy, and IgA nephropathy14 monthsfemales

   Triple Renal Pathology in a Patient With Myeloperoxidase-Associated Vasculitis, Diabetic Nephropathy, and Immunoglobulin A Nephropathy: A Case Report

   Cureus·13 Sep 2026

More on Urine protein-to-creatinine ratio

1. Multimodal therapeutic approach is associated with MPO antibody titer in humans (677 AI to 28 AI).

   “Over 14 months, her serum creatinine stabilized at 1.45 mg/dL, MPO titers decreased to 28 AI, and proteinuria improved to ~6,200 mg/g.”

   HumansOverlapping ANCA-associated vasculitis, diabetic nephropathy, and IgA nephropathy14 monthsfemales

   Triple Renal Pathology in a Patient With Myeloperoxidase-Associated Vasculitis, Diabetic Nephropathy, and Immunoglobulin A Nephropathy: A Case Report

   Cureus·13 Sep 2026

More on MPO antibody titer

1. Multimodal therapeutic approach is associated with serum creatinine in humans (Peak 5.2 mg/dL; stabilized at 1.45 mg/dL).

   “Over 14 months, her serum creatinine stabilized at 1.45 mg/dL, MPO titers decreased to 28 AI, and proteinuria improved to ~6,200 mg/g.”

   HumansOverlapping ANCA-associated vasculitis, diabetic nephropathy, and IgA nephropathy14 monthsfemales

   Triple Renal Pathology in a Patient With Myeloperoxidase-Associated Vasculitis, Diabetic Nephropathy, and Immunoglobulin A Nephropathy: A Case Report

   Cureus·13 Sep 2026

More on Serum creatinine